【参考文献】
1 Williams R, Airey M, Baxter H, et al. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 2004;18(10):963983
2葛坚.眼科学.北京:人民卫生出版社 2005:304305
3 Kohner EM. Microvascular disease: what does the UKPDS tell us about diabetic retinopathy? Diabet Med 2008;25(2):2024
4 Hochstrasser DF, Banks RE, Dunn MJ, et al. Proteomics and its trends facing nature’s complexity. Proteomics 2002;2(7):807812
5郭疆,吴开力,余敏斌.眼蛋白质组学.眼科学报 2003;19(2):6770
6肖迎,唐仕波.视网膜疾病的蛋白质组研究.中华眼底病杂志 2005;21(3):199202
7 Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabet Med 2005;22(4):359370
8刘尚清,张艳艳,羊惠君,等.早期糖尿病大鼠视网膜蛋白质表达变化的初步研究.眼科研究 2007;25(3):186189
9 Liu S,Zhang Y,Xie X, et al. Application of twodimensional electrophoresis in the research of retinal proteins of diabetic rat. Cell Mol Immunol 2007;4(1):6570
10 Quin GG, Len AC, Billson FA, et al. Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy. Proteomics 2007;7(15):26362650
11 Kamradt MC, Chen F, Cryns VL. The small heat shock protein alpha Bcrystallin negatively regulates cytochrome c and caspase8dependent activation of caspase3 by inhibiting its autoproteolytic maturation. J Biol
Chem 2001;276(19):1605916063
12 Wang YD, Wu JD, Jiang ZL, et al. Comparative proteome analysis of neural retinas from type 2 diabetic rats by twodimensional electrophoresis. Curr Eye Res 2007;32(10):891901
13 Fort PE, Freeman WM, Losiewicz MK, et al. The retinal proteome in experimental diabetic retinopathy: upregulation of crystallins and reversal by systemic and periocular insulin. Mol Cell Proteomics 2009;8(4):767779
14 Li M, Ma YB, Gao HQ, et al. A novel approach of proteomics to study the mechanism of action of grape seed proanthocyanidin extracts on diabetic retinopathy in rats. Chin Med J 2008;121(24):25442552
15 Gao BB, Chen X, Timothy N, et al. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabeticretinopathy. J Proteome Res 2008;7(6):25162525
16 Kim SJ, Kim S, Park J, et al. Differential expression of vitreous proteins in proliferative diabetic retinopathy. Curr Eye Res 2006;31(3):231240
17 Kim T, Kim SJ, Kim K, et al. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics 2007;7(22):42034215
18 Sramek SJ, Wallow IH, Tewksbury DA, et al. An ocular reninangiotensin ystem.Immunohistochemistry of angiotensinogen. Invest Ophthalmol Vis
Sci 1992;33(5):16271632
19 GarciaRamirez M, Canals F, Hernandez C, et al. Proteomic analysis of human vitreous fluid by fluorescencebased difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy. Diabetologia 2007;50(6):12941303
20 Simo R, Higuera M, GarciaRamirez M, et al. Elevation of apolipoprotein AI and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients. Arch Ophthalmol 2008;126(8):10761081
21 Klein R, Klein BE, Moss SE, et al. The wisconsin epidemiologic study of diabetic retinopathy diabetic macular edema. Ophthalmology 1984;91(12):14641474
22 Ouchi M, West K, Crabb JW, et al. Proteomic analysis of vitreous from diabetic macular edema. Exp Eye Res 2005;81(2):176182
23 Decanini A, Karunadharma PR, Nordgaard CL, et al. Human retinal pigment epithelium proteome changes in early diabetes. Diabetologia 2008;51(6):10511061
24 Ahn BY, Song ES, Cho YJ, et al. Identification of an antialdolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis. Proteomics 2006;6(4):12001209 上一页 [1] [2] [3] |